back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-01-02 22:43 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
$82,800
+180,000 vol $0.46 each |
450,000 | |
| Filed 2024-01-02 22:41 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$23,998
+52,171 vol $0.46 each |
997,771 | |
| Filed 2023-12-29 15:56 Tx date 2023-12-28 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: Spouse's TFSA (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,644
+15,100 vol $0.44 each |
49,600 | |
| Filed 2023-12-29 15:55 Tx date 2023-12-27 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: Spouse's TFSA (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,870
+34,500 vol $0.46 each |
34,500 | |
| Filed 2023-12-29 15:54 Tx date 2017-04-17 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: Spouse's TFSA (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-12-29 15:47 Tx date 2023-12-27 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,030
+21,000 vol $0.43 each |
32,800 | |
| Filed 2023-12-29 15:40 Tx date 2023-12-27 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,350
+10,000 vol $0.435 each |
659,351 | |
| Filed 2023-09-05 12:52 Tx date 2023-08-31 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$34,848
+52,800 vol $0.66 each |
945,600 | |
| Filed 2023-06-25 22:55 Tx date 2023-06-20 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$34,320
+52,800 vol $0.65 each |
892,800 | |
| Filed 2022-01-05 11:49 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+120,000 vol |
270,000 | |
| Filed 2022-01-05 11:13 Tx date 2022-01-03 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+120,000 vol |
840,000 | |
| Filed 2021-12-17 16:47 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$310.00
+500 vol $0.62 each |
11,800 | |
| Filed 2021-12-17 16:46 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,860
+3,000 vol $0.62 each |
11,300 | |
| Filed 2021-12-17 16:45 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,250
+5,000 vol $0.65 each |
8,300 | |
| Filed 2021-12-17 16:45 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,300
+2,000 vol $0.65 each |
3,300 | |
| Filed 2021-12-17 16:44 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$650.00
+1,000 vol $0.65 each |
1,300 | |
| Filed 2021-12-17 16:42 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$195.00
+300 vol $0.65 each |
300 | |
| Filed 2021-12-17 16:42 Tx date 2017-04-17 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-01-06 13:57 Tx date 2021-01-01 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+150,000 vol |
150,000 | |
| Filed 2021-01-05 22:03 Tx date 2017-04-17 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-01-05 21:55 Tx date 2021-01-01 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
720,000 | |
| Filed 2020-08-21 22:09 Tx date 2020-08-17 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$108,000
+180,000 vol $0.60 each |
630,000 | |
| Filed 2019-01-08 Tx date 2019-01-04 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
450,000 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+180,000 vol |
250,000 | |
| Filed 2018-03-16 Tx date 2018-02-16 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+542,484 vol |
542,484 | |
| Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-287,516.52
-542,484 vol $0.53 each |
0 | |
| Filed 2018-03-16 Tx date 2017-04-17 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$143,758
+271,242 vol $0.53 each |
649,351 | |
| Filed 2017-12-07 Tx date 2017-12-05 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,250
+15,000 vol $0.55 each |
378,109 | |
| Filed 2017-12-07 Tx date 2017-12-05 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$159,813
+275,541 vol $0.58 each |
363,109 | |
| Filed 2017-08-24 Tx date 2017-08-24 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$50,000
+67,568 vol $0.74 each |
87,568 | |
| Filed 2017-07-04 Tx date 2017-06-30 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$990.00
+1,500 vol $0.66 each |
20,000 | |
| Filed 2017-07-04 Tx date 2017-06-30 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,300
+2,000 vol $0.65 each |
18,500 | |
| Filed 2017-07-04 Tx date 2017-06-30 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$360.00
+500 vol $0.72 each |
16,500 | |
| Filed 2017-07-04 Tx date 2017-06-30 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,450
+3,500 vol $0.70 each |
16,000 | |
| Filed 2017-07-04 Tx date 2017-06-30 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$670.00
+1,000 vol $0.67 each |
12,500 | |
| Filed 2017-07-04 Tx date 2017-06-30 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,625
+11,500 vol $0.75 each |
11,500 | |
| Filed 2017-07-04 Tx date 2017-04-17 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-28 Tx date 2017-06-28 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+70,000 vol |
70,000 | |
| Filed 2017-06-28 Tx date 2017-04-17 |
$CTX
Crescita Therapeutics Inc. |
Verreault, Serge
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|